| Announce Date | 05/16/2025 |
| EPS Normalized Actual | $-0.14 (Miss by $-0.18) |
| EPS GAAP Actual | $-0.14 (Miss by $-0.18) |
| Revenue Actual | $0.00277585B |
| Revenue Surprise | Beat by $2.77585M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.08 |
| EPS GAAP Estimate | $0.08 |
| Revenue Estimate | $0.04022B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2027 | -0.08 | -52 | -0.08 | -0.08 | 1 |
| Jun 2026 | -0.08 | -52 | -0.08 | -0.08 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.11 | -0.11 | 0.00277585B | 87.63% | 2.78M |
| FQ3 2025 (Sep 2025) | -0.0918 | -0.0618 | 0.000937589B | 78.46% | -19.17M |
| FQ2 2019 (Jun 2019) | -0.13 | -0.13 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.45 | -0.45 | 0.0003435B | 100% | 0.34M |
| FQ3 2024 (Sep 2024) | -0.17 | -1.71141 | 0.00020196B | 100% | 0.2M |
| FQ4 2024 (Dec 2024) | -0.18 | -0.15 | 0.00033244B | 100% | -19.67M |
| FQ1 2025 (Mar 2025) | -0.14 | -0.18 | 0.000979977B | 100% | -29.02M |
| FQ1 2024 (Mar 2024) | -0.19 | -0.16 | 0B | NAN% | -20.1M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.08
Consensus Revenue Estimates
0.04022B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.08 | -- | 0.08 | 0.08 | 1 |
| FQ4 2026 (Dec 2026) | 0.04 | -- | 0.04 | 0.04 | 1 |
| FQ3 2026 (Sep 2026) | -0.03 | -206 | -0.03 | -0.03 | 1 |
| FQ1 2026 (Mar 2026) | 0.08 | 275 | 0.06488889 | 0.0952 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ3 2026 (Sep 2026) | 0.02B | 95.34 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.04B | 97.56 | 0.03B | 0.05B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
4
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.11 | -0.11 | 100% | |
| FQ3 2025 (Sep 2025) | -0.03 | -0.0918 | -0.0618 | 67.32% |
| FQ2 2019 (Jun 2019) | -0.13 | -0.13 | 100% | |
| FQ2 2024 (Jun 2024) | -0.45 | -0.45 | 100% | |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.17 | -1.71141 | 1006.71% |
| FQ4 2024 (Dec 2024) | -0.03 | -0.18 | -0.15 | 83.33% |
| FQ1 2025 (Mar 2025) | 0.04 | -0.14 | -0.18 | 128.57% |
| FQ1 2024 (Mar 2024) | -0.03 | -0.19 | -0.16 | 84.21% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0B | $2.78M | 100% |
| FQ3 2025 (Sep 2025) | $0.02B | $0B | $-19.17M | -2044.86% |
| FQ2 2019 (Jun 2019) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0.34M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0.2M | 100% |
| FQ4 2024 (Dec 2024) | $0.02B | $0B | $-19.67M | -5916.12% |
| FQ1 2025 (Mar 2025) | $0.03B | $0B | $-29.02M | -2961.3% |
| FQ1 2024 (Mar 2024) | $0.02B | $0B | $-20.1M | -INF% |